India High Court Rules Against Schering-Plough In Trademark Case
This article was originally published in PharmAsia News
Executive SummaryIndia's Bombay High Court rejected an injunction sought against United Biotech and Oscar Remedies in a dispute over the Schering-Plough antibacterial drug Netromycin (netilmicin)
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.